Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rovical-D
- Development stage
- Unknown
- Lead developer
- Rosetta Lifecare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rovical-D is a veterinary nutritional supplement developed by Rosetta Lifecare. It is formulated as an oral suspension or liquid containing a balanced combination of essential minerals and vitamins, including calcium, phosphorus, vitamin D3, vitamin A, vitamin B12, vitamin E, biotin, and iron. The supplement is designed for pets (such as dogs, cats, puppies, and kittens) and livestock to promote healthy bone and teeth development, particularly during periods of rapid growth. It is also indicated for the management and prevention of hypocalcemia, iron deficiencies, and to support overall bone strength.
- Brand names
- Rovical-DRovical-D Strong
- Other names
- Rovical-D Pet Suspension
02
Targets
CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Rovical-D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rovical-D.